» Articles » PMID: 38310208

Focused Ultrasound Versus the Loop Electrosurgical Excision Procedure to Treat Women with Cervical High-grade Squamous Intraepithelial Lesions Under 40: a Retrospective Study

Overview
Journal BMC Cancer
Publisher Biomed Central
Specialty Oncology
Date 2024 Feb 3
PMID 38310208
Authors
Affiliations
Soon will be listed here.
Abstract

Background: This study aimed to compare the efficacy of focused ultrasound (FUS) and the loop electrosurgical excision procedure (LEEP) for the treatment of cervical high-grade squamous intraepithelial lesions (HSILs) among women of reproductive age.

Methods: Case records of patients aged < 40 years who were treated for cervical HSILs using either FUS or LEEP from September 1, 2020 to May 31, 2022 were retrospectively reviewed. Patients were followed up for cure, recurrence, human papillomavirus (HPV) clearance, and complications within 1 year of treatment. Odds ratios and 95% confidence intervals were determined using univariate and multivariate logistic regression models to analyze the association between disease evidence or HPV clearance and treatment modalities or other covariates.

Results: Of the 1,054 women who underwent FUS or LEEP, 225 met our selection criteria. Among the selected women, 101 and 124 received FUS and LEEP, respectively. There was no significant difference between the FUS and LEEP groups in the cure rate during the 3-6 months of follow-up (89.11% vs. 94.35%, P = 0.085) and recurrence rate during the 6-12 months follow-up (2.22% vs. 1.71%, P = 0.790). Both groups exhibited enhanced cumulative HPV clearance rates; however, the rates were not significantly different between the FUS and LEEP groups (74.23% vs. 82.79%, P = 0.122 during the 3-6 months follow-up; 84.95% vs. 89.17%, P = 0.359 during the 6-12 months follow-up). Furthermore, the incidence of complications caused by the FUS and LEEP techniques was comparable (5.0% vs. 5.6%, P = 0.818).

Conclusions: We found that FUS and LEEP have similar efficacy, safety, and reliability in treating women (aged < 40 years) with HSILs.

References
1.
Bosch F, Lorincz A, Munoz N, Meijer C, Shah K . The causal relation between human papillomavirus and cervical cancer. J Clin Pathol. 2002; 55(4):244-65. PMC: 1769629. DOI: 10.1136/jcp.55.4.244. View

2.
Brockmeyer A, Wright J, Gao F, Powell M . Persistent and recurrent cervical dysplasia after loop electrosurgical excision procedure. Am J Obstet Gynecol. 2005; 192(5):1379-81. DOI: 10.1016/j.ajog.2004.12.044. View

3.
Rabasa J, Bradbury M, Sanchez-Iglesias J, Guerrero D, Forcada C, Alcalde A . Evaluation of the intraoperative human papillomavirus test as a marker of early cure at 12 months after electrosurgical excision procedure in women with cervical high-grade squamous intraepithelial lesion: a prospective cohort study. BJOG. 2019; 127(1):99-105. DOI: 10.1111/1471-0528.15932. View

4.
Pinder L, Parham G, Basu P, Muwonge R, Lucas E, Nyambe N . Thermal ablation versus cryotherapy or loop excision to treat women positive for cervical precancer on visual inspection with acetic acid test: pilot phase of a randomised controlled trial. Lancet Oncol. 2019; 21(1):175-184. PMC: 6946855. DOI: 10.1016/S1470-2045(19)30635-7. View

5.
Perkins R, Guido R, Castle P, Chelmow D, Einstein M, Garcia F . 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors. J Low Genit Tract Dis. 2020; 24(2):102-131. PMC: 7147428. DOI: 10.1097/LGT.0000000000000525. View